Inventiva (IVEVF) Total Debt (2018 - 2025)
Inventiva (IVEVF) posted Total Debt of $69.7 million for Q4 2025, down 38.06% on a QoQ basis from $112.5 million in Q2 2025, and down 57.11% year-over-year from $162.5 million in Q4 2024.
Analysis
Inventiva (IVEVF) Total Debt (2018 - 2025) Analysis & Trends
Inventiva has reported Total Debt for 8 years, with the latest figure at $69.7 million in Q4 2025.
- On a quarterly basis, Total Debt fell 57.11% year-over-year to $69.7 million in Q4 2025; TTM through Dec 2025 was $69.7 million, a 57.11% decrease from a year earlier, with the FY2025 full-year figure at $69.7 million, down 57.11% from the prior year.
- Total Debt was $69.7 million for Q4 2025 at Inventiva, down from $112.5 million in the prior quarter.
- The five-year high for Total Debt was $162.5 million in Q4 2024, with the low at $11.6 million in Q4 2021.
- Average Total Debt over 5 years is $56.3 million, with a median of $47.2 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2025: Total Debt jumped 291.24% in 2022, then slumped 57.11% in 2025.
- Over 5 years, Total Debt stood at $11.6 million in 2021, then surged by 291.24% to $45.3 million in 2022, then rose by 21.3% to $54.9 million in 2023, then soared by 195.75% to $162.5 million in 2024, then plunged by 57.11% to $69.7 million in 2025.
- The last three Total Debt figures came in at $69.7 million (Q4 2025), $112.5 million (Q2 2025), and $162.5 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.71 Bn | 625.95 Bn | 17.26 Bn | 60.73 Bn |
| 2 | AbbVie | 442.22 Bn | 435.65 Bn | 12.70 Bn | 70.82 Bn |
| 3 | Merck | 366.92 Bn | 359.78 Bn | 12.21 Bn | 53.91 Bn |
| 4 | Novartis Ag | 266.90 Bn | 259.21 Bn | 11.24 Bn | 9.59 Bn |
| 5 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn | 63.19 Bn |
| 6 | Sanofi | 52.44 Bn | 45.06 Bn | 10.79 Bn | 25.19 Bn |
| 7 | Revolution Medicines | 44.11 Bn | 44.11 Bn | - | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | 38.81 Mn |
| 9 | United Therapeutics | 21.50 Bn | 18.84 Bn | 683.80 Mn | - |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - | 69.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 69.68 Mn |
| Jun 30, 2025 | 112.50 Mn |
| Dec 31, 2024 | 162.47 Mn |
| Jun 30, 2024 | 71.23 Mn |
| Dec 31, 2023 | 54.94 Mn |
| Jun 30, 2023 | 47.25 Mn |
| Dec 31, 2022 | 45.29 Mn |
| Jun 30, 2022 | 19.77 Mn |
| Dec 31, 2021 | 11.58 Mn |
| Jun 30, 2021 | 12.15 Mn |
| Mar 31, 2021 | 12.17 Mn |
| Dec 31, 2020 | 11.99 Mn |
| Jun 30, 2020 | 11.04 Mn |
| Dec 31, 2019 | 127,292.08 |
| Dec 31, 2018 | 429,165.06 |